من السبت الى الخميس (8:00AM-2:00PM)
تواصل معنا : +9647716699096







  • م.د علي غازي حمدي
  • Lecturer Dr. Ali Ghazi Hamdi
  • تدريسي : طب الاسنان
  • Teaching : Collage of Dentistry
  • دكتوراة تقنيات أحيائية
  • PhD Biotechnology
  • dr.alighazi@bauc14.edu.iq
  • dr.alialdulimi@gmali.com
  • المقررات المكلف بها

    المقررات المكلف بها - 3
    القسم المرحلة الفصل رمز المقرر الوحدات توصيف المقرر
    طب الاسنان المرحلة الثالثة سنوي 6 الاحياء المجهرية Microbiology
    طب الاسنان المرحلة الثالثة سنوي 6 الامراض العامة General Pathology
    طب الاسنان المرحلة الثانية سنوي 6 الكيمياء الحياتية Biochemistry

    المحاضرات الالكترونية

    المحاضرات الالكترونية - 26
    العام المقرر القسم المرحلة المحاضرة
    2024-2025 الكيمياء الحياتية Biochemistry طب الاسنان المرحلة الثانية vitamins
    2024-2025 الكيمياء الحياتية Biochemistry طب الاسنان المرحلة الثانية vitamins (D)
    2024-2025 الكيمياء الحياتية Biochemistry طب الاسنان المرحلة الثانية Vitamin E & B
    2024-2025 الكيمياء الحياتية Biochemistry طب الاسنان المرحلة الثانية vitamin C
    2024-2025 الكيمياء الحياتية Biochemistry طب الاسنان المرحلة الثانية hormons
    2024-2025 الكيمياء الحياتية Biochemistry طب الاسنان المرحلة الثانية lipids
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Antimicrobial agents
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Tolerance
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Sterilization
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Organs of immune system
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Antibodies
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Antigen
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Immunity
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Bacterial Growth
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Bacterial Cell Wall
    2024-2025 الاحياء المجهرية Microbiology طب الاسنان المرحلة الثالثة Bacterial cell
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Genetic Disease
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Congestion
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Hemodynamic Disorders
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Hallmarks of cancer
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Neoplasia
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Inflamation
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Cellular Damge
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Hypoxai
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Adaptation
    2024-2025 الامراض العامة General Pathology طب الاسنان المرحلة الثالثة Introduction of pathology

    البحوث

    2020 Journal of Materials Research and Technology
    L-asparaginase is an amidohydrolase enzyme that is widely identified as one of the most potential anti cancerous drugs. Nevertheless, this drug is poorly bioavailable and hence its pharmaceutical uses are limited. To improve its bioactivity, L-asparaginase was loaded on gold nanoparticles (GNPs) along with Arg-Gly-Asp (RGD) peptide that direct the enzyme to targeted cancer cells with aim to enhancing the anticancer efficiency. Successful preparation of GNPs and the conjugate (GNPs-PEG-L-asparaginase-RGD) was verified and delineated by employing UVeVIS spectrophotometer, FTIR, XRD, FE-SEM, and TEM. UVeVIS spectrophotometer, Fourier Transform Infrared (FT-IR), X-Ray Diffraction (XRD), Field Emission Scanning Electron Microscopic (FE-SEM), and Transmission Electron Microscopy (TEM). The efficiency of the GNPs and conjugate to target and distribute in MCF-7 cells was evaluated using high fluorescent signals and confirmed by fluorescence microscopy. A variety of parameters were tested to investigate the anticancer potential of each compound toward MCF-7 cells in vitro. The conjugate demonstrated significant antioxidant effects with high tumor targeting efficacy and distribution in MCF-7 cells. It caused a decrease in cell proliferation rate and clonogenicity of MCF-7 cells, while initiating apoptosis and promoting cell cyceffects were coupled with upregulating the pro-apoptotic p53 while downregulating the anti-apoptotic Bcl-2, which resulted in an alleviation of the mitochondrial membrane potential (MMP) and, thereby, the secretion of cytochrome c. The outcomes of the present study propose the high feasibility for further development of the conjugate as a novel agent against cancer cells

    Journal of Medical and Life Science
    Gold nanoparticles (GNPs) act as less toxic and effective drug carriers with many specific properties that are particularly useful for biomedical and pharmaceutical applications. The present study was conducted to determine the anti-tumor properties GNPs. The new preparation technique is quick and cost-effective. GNPs formation was confirmed using various characterization techniques including X‐Ray diffraction (XRD) analysis, field emission scanning electron microscopy (FE-SEM), energy dispersive X-ray spectrometer (EDX), and transmission electron microscopy (TEM). XRD, FES-EM, and TEM experiments have confirmed the formation of GNPs which shows that the prepared particles are spherical inform and have a smooth surface with an average size of 24.32 ± 1.32 nm. Multiparametric analysis of GNPs toxicity at the level of individual cells using flow cytometry and cellular imaging-based approaches such as High Content Screening (HCS) have played key roles in the detection of toxicity and classification of compounds based on observed patterns of reversible and irreversible cellular injury. The effect of GNPs on the MCF-7 cell line regarding cell viability, cell nucleus morphology, membrane permeability, potential mitochondrial permeability, and cytochrome C release was further confirmed using a High Content Screening array scan via multi-parametric kit. Results indicated that the viable count of MCF-7 cells was highly decreased by treated with GNPs. Nuclei stained with Hoechst blue appeared to be mostly condensed in response to the treatment with the GNPs (1.5- fold increase in nuclear fluorescence intensity), with significant differences (p < 0.0263) as compared with untreated cells. Cell membrane permeability was significantly (p = 0.0019) upon GNPs showing an increase of 1.9-fold, as compared with the untreated MCF-7 cells. GNPs induce a significant (p = 0.0053) decrease in mitochondrial membrane potential by 32.7%, in comparison to the untreated cancer cells with significant induction of the release of cytochrome C (p = 0.0016) was recorded after exposure to the GNPs (0.43-fold increased mean intensity), The outcomes of the present study propose the high feasibility for using GNPs as a novel anticancer drug.

    2021 Doctorate thesis, College of Biotechnology, Al-Nahrain Universit
    specific properties that are particularly useful for biomedical and pharmaceutical applications. The present study was conducted to determine the antioxidant and anti-tumor properties of fabricated GNPs-RGD (Arg-Gly-Asp peptide)-L-asparaginase (L-ASNase) conjugate. The preparation of GNPs-RGD-L-ASNase conjugate was firstly initiated by GNPs synthesis then encapsulation with SH-PEG-COOH accompanied by incubation with RGD and L-ASNase. The new preparation technique is quick and cost effective. GNPs and GNPs-RGD-L-ASNase conjugate formation were confirmed using various characterization techniques including: UV–visible spectroscopy, Fourier transform infrared spectroscopy (FTIR) analysis, X‐Ray diffraction (XRD) analysis, field emission scanning electron microscopy (FE-SEM), energy dispersive X-ray spectrometer (EDX) and transmission electron microscopy (TEM). UV-visible spectroscopy was used to detect the size and shape of the GNPs and GNPs-RGD-L-ASNase conjugate. The FTIR analysis was used to test the molecular states and functional groups of GNPs and GNPs-RGD-L-ASNase conjugate. XRD, FES-EM and TEM experiments have confirmed the formation of GNPs and GNPs-RGD-L-ASNase conjugate which shown that the prepared particles are spherical in form and have a smooth surface with an average size of 19.55±2.61 nm and 29.24±5.38 nm for GNPs and GNPs-RGD-L-ASNase conjugate respectively. L-ASNase activity in the GNPs-RGD-L-ASNase conjugate was detected by a direct nesslerization method

    2023 ANNALS OF FOREST RESEARCH
    Different plant sections from (Laurus nobilis, Malus domestica, and Citrus limon) were extracted using 80% methanol. All plants were then evaluated phytochemically for total flavonoids, with different concentrations of 952.77173.47, 980.55673.57, and 341.6683.33 mg/ml, respectively. Additionally, all plant extracts outperformed trolox in terms of their ability to reduce. Additionally, plants' radical scavenging abilities are stronger than vitamin C. (positive control). Some active plant chemicals, including hesperidin, quercetin-3-rhamnoside, and Q-3-O-B-glucopyranoside, underwent molecular docking. Due to its chemical structure, hesperidin had a stronger binding affinity with the active site of human kidenny type l-glutaminase (KGA) with a binding energy of (-7.09 kcal/mol) than the reference (crystal ligand), which had a binding energy of (-6.96 kcal/mol). Hesperidin peak is shown by HPLC analysis of Citrus limon methanolic extract at retention time 14.80 ppm. Purified hesperidin provided an inhibition of 65.33% for standard KGA in an in vitro inhibitory experiment when compared to CB-839 positive control. Using RT PCR, the GLS1 gene expression levels in the AMJ13 cell line were assessed after treatment with hesperidin and CB-839. The results revealed that hesperidin suppressed GLS1 gene expression in the cancer cell line while CB-839 increased GLS1 gene expression. Keywords: Hesperidin; molecular docking; KGA; breast cancer; GLS1gene expression

    2016 university of Diyala




    En